MIAMI, April 22, 2025 (Newswire.com) – Promptly, the leading All-in-One Patient Experience Suite, today announced the strategic acquisition of MDprospects and

BILLERICA, Mass. and MARLBOROUGH, Mass.–Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences

Proposed acquisition adds Nimble’s lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline

Miami, FL – Promptly Technology, Inc., a leader in streamlining patient engagement, secured strategic minority investments led by Telegraph Hill

PHILADELPHIA, April 1, 2024 /PRNewswire/ — ObservSMART, a leading proximity-based technology system for ensuring patient safety in healthcare settings, proudly announces

EditCo is focused on the development and manufacture of highly optimized CRISPR guide RNA designs and edited cells for the

Company Announces Appointment of Daniel Flynn, Ph.D. and Brian Cali, Ph.D. to Strengthen Capabilities in Support of Company’s Peptide Drug

Investment strengthens Argonaut’s leadership position in sterile fill / finish and expands the Company’s aseptic drug product manufacturing capabilities in

Pleasanton, California – February 7, 2024 – n6 Tec Inc., a next generation sequencing and molecular biology platform company, announced

iconPCR enables optimal high-throughput PCR for next generation sequencing and molecular biology applications PLEASANTON, CA – February 6, 2024— n6